+ADw-html xmlns:v+AD0AIg-urn:schemas-microsoft-com:vml+ACI- xmlns:o+AD0AIg-urn:schemas-microsoft-com:office:office+ACI- xmlns:w+AD0AIg-urn:schemas-microsoft-com:office:word+ACI- xmlns:st1+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- xmlns+AD0AIg-http://www.w3.org/TR/REC-html40+ACIAPg- +ADw-head+AD4- +ADw-meta http-equiv+AD0-Content-Type content+AD0AIg-text/html+ADs- charset+AD0-utf-7+ACIAPg- +ADw-meta name+AD0-ProgId content+AD0-Word.Document+AD4- +ADw-meta name+AD0-Generator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-meta name+AD0-Originator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-link rel+AD0-File-List href+AD0AIg-als24345+AF8-files/filelist.xml+ACIAPg- +ADw-link rel+AD0-Edit-Time-Data href+AD0AIg-als24345+AF8-files/editdata.mso+ACIAPg- +ADwAIQ---+AFs-if +ACE-mso+AF0APg- +ADw-style+AD4- v+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- o+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- w+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- .shape +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-title+AD4-Anti-PRG3 antibodies from RDI Division of Fitzgerald Industries Intl+ADw-/title+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-country-region+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-PostalCode+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-State+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-City+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-Street+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-address+ACI-/+AD4- +ADw-o:SmartTagType namespaceuri+AD0AIg-urn:schemas-microsoft-com:office:smarttags+ACI- name+AD0AIg-place+ACI-/+AD4- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:DocumentProperties+AD4- +ADw-o:Author+AD4-Martha Rozynski+ADw-/o:Author+AD4- +ADw-o:LastAuthor+AD4-Martha Rozynski+ADw-/o:LastAuthor+AD4- +ADw-o:Revision+AD4-2+ADw-/o:Revision+AD4- +ADw-o:TotalTime+AD4-0+ADw-/o:TotalTime+AD4- +ADw-o:Created+AD4-2008-05-16T21:10:00Z+ADw-/o:Created+AD4- +ADw-o:LastSaved+AD4-2008-05-16T21:10:00Z+ADw-/o:LastSaved+AD4- +ADw-o:Pages+AD4-1+ADw-/o:Pages+AD4- +ADw-o:Words+AD4-354+ADw-/o:Words+AD4- +ADw-o:Characters+AD4-2022+ADw-/o:Characters+AD4- +ADw-o:Company+AD4-Trinity Biotech USA+ADw-/o:Company+AD4- +ADw-o:Lines+AD4-16+ADw-/o:Lines+AD4- +ADw-o:Paragraphs+AD4-4+ADw-/o:Paragraphs+AD4- +ADw-o:CharactersWithSpaces+AD4-2372+ADw-/o:CharactersWithSpaces+AD4- +ADw-o:Version+AD4-11.9999+ADw-/o:Version+AD4- +ADw-/o:DocumentProperties+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:WordDocument+AD4- +ADw-w:GrammarState+AD4-Clean+ADw-/w:GrammarState+AD4- +ADw-w:ValidateAgainstSchemas/+AD4- +ADw-w:SaveIfXMLInvalid+AD4-false+ADw-/w:SaveIfXMLInvalid+AD4- +ADw-w:IgnoreMixedContent+AD4-false+ADw-/w:IgnoreMixedContent+AD4- +ADw-w:AlwaysShowPlaceholderText+AD4-false+ADw-/w:AlwaysShowPlaceholderText+AD4- +ADw-w:BrowserLevel+AD4-MicrosoftInternetExplorer4+ADw-/w:BrowserLevel+AD4- +ADw-/w:WordDocument+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:LatentStyles DefLockedState+AD0AIg-false+ACI- LatentStyleCount+AD0AIg-156+ACIAPg- +ADw-/w:LatentStyles+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if +ACE-mso+AF0APgA8-object classid+AD0AIg-clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D+ACI- id+AD0-ieooui+AD4APA-/object+AD4- +ADw-style+AD4- st1+AFw-:+ACoAew-behavior:url(+ACM-ieooui) +AH0- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-style+AD4- +ADwAIQ--- /+ACo- Style Definitions +ACo-/ p.MsoNormal, li.MsoNormal, div.MsoNormal +AHs-mso-style-parent:+ACIAIgA7- margin:0in+ADs- margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- p +AHs-font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- span.GramE +AHs-mso-style-name:+ACIAIgA7- mso-gram-e:yes+ADsAfQ- +AEA-page Section1 +AHs-size:8.5in 11.0in+ADs- margin:1.0in 1.25in 1.0in 1.25in+ADs- mso-header-margin:.5in+ADs- mso-footer-margin:.5in+ADs- mso-paper-source:0+ADsAfQ- div.Section1 +AHs-page:Section1+ADsAfQ- --+AD4- +ADw-/style+AD4- +ADwAIQ---+AFs-if gte mso 10+AF0APg- +ADw-style+AD4- /+ACo- Style Definitions +ACo-/ table.MsoNormalTable +AHs-mso-style-name:+ACI-Table Normal+ACIAOw- mso-tstyle-rowband-size:0+ADs- mso-tstyle-colband-size:0+ADs- mso-style-noshow:yes+ADs- mso-style-parent:+ACIAIgA7- mso-padding-alt:0in 5.4pt 0in 5.4pt+ADs- mso-para-margin:0in+ADs- mso-para-margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:10.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-ansi-language:+ACM-0400+ADs- mso-fareast-language:+ACM-0400+ADs- mso-bidi-language:+ACM-0400+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-meta name+AD0-description content+AD0AIg-Anti-PRG3 antibodies from RDI Divison of Fitzgerald Industries Intl.+ACIAPg- +ADw-meta name+AD0-keywords content+AD0AIg-rdi-als24345, prg3, p53 target gene,+ACIAPg- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapedefaults v:ext+AD0AIg-edit+ACI- spidmax+AD0AIg-2050+ACI-/+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:shapelayout v:ext+AD0AIg-edit+ACIAPg- +ADw-o:idmap v:ext+AD0AIg-edit+ACI- data+AD0AIg-1+ACI-/+AD4- +ADw-/o:shapelayout+AD4APA-/xml+AD4APAAhAFs-endif+AF0---+AD4- +ADw-/head+AD4- +ADw-body lang+AD0-EN-US link+AD0-blue vlink+AD0-blue style+AD0-'tab-interval:.5in'+AD4- +ADw-div class+AD0-Section1+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-rev+ADw-/span+AD4-: +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs-5/16/2008+ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/index.htm+ACIAPg-HOME+ADw-/a+AD4- +ACY-nbsp+ADs- (index page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4APA-br+AD4- +ADw-b+AD4AJg-nbsp+ADs- ANTIBODIES+ADw-/b+AD4- +ACY-nbsp+ADs- +ADw-/p+AD4- +ADw-p align+AD0-center style+AD0-'text-align:center'+AD4-(+ADw-span class+AD0-GramE+AD4-anti-Human+ADw-/span+AD4- and others as indicated) +ADw-/p+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries +ADw-span class+AD0-GramE+AD4-Intl +ACY-nbsp+ADs-offers+ADw-/span+AD4- a wide line of +ACY-nbsp+ADs-antibodies. Since no one antibody works best for all applications (neutralization, blotting, ELISA, etc), we offer many different types of antibodies to help solve this problem. Please inquire for other applications or types of antibodies not listed below. +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p class+AD0-MsoNormal+AD4APA-b+AD4-Anti-PRG3 Polyclonal Antibody+ADw-/b+AD4- +ADw-/p+AD4- +ADw-p+AD4-Catalog Number: RDI-ALS24345 +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADsAJA-315.00/100ug +ADw-/p+AD4- +ADw-p+AD4AJg-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADsAJg-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs- +ACY-nbsp+ADs-RDI-ALS24345X +ACY-nbsp+ADs- +ACQ-1875.01/mg +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPg-Lot+ADw-/st1:place+AD4- Number: +ADw-/p+AD4- +ADw-p+AD4-Quantity: 100ug in 100ul (1 mg/ml) in PBS containing 0.02+ACU- sodium azide. +ADw-/p+AD4- +ADw-p+AD4-Description: The p53 tumor suppressor protein induces cell cycle arrest or apoptosis in response to cellular stresses. PRG3 (p53-responsive gene 3), is induced specifically under p53-dependent apoptotic conditions in human colon cancer cells. PRG3 has significant homology to bacterial oxidoreductases and the apoptosis-inducing factor, AIF. Unlike AIF, PRG3 localizes in the cytoplasm and its ectopic expression induces apoptosis. The PRG3 gene is thus a novel p53 target gene in a p53-dependent apoptosis pathway. +ADw-/p+AD4- +ADw-p+AD4-Host Species: Rabbit +ADw-/p+AD4- +ADw-p+AD4-Specificity: Reacts with residues 170-185 +AFs-VTLIHSQVALADKELL+AF0- of the 41 kDa human PRG3 protein. This sequence is 87+ACU- identical in mouse. +ADw-/p+AD4- +ADw-p+AD4-Applications: Western blot - Use at 1:500 +ADw-span class+AD0-GramE+AD4-dilution+ADw-/span+AD4-. However, the investigator should determine the optimal dilution for a specific application such as immunohistochemistry. +ADw-/p+AD4- +ADw-p+AD4-Format: Affinity purified IgG +ADw-/p+AD4- +ADw-p+AD4-Storage: Maintain at 8+ALA-C for 3 months or at -20+ALA-C for longer periods. +ADw-span class+AD0-GramE+AD4-Stable for 1 year.+ADw-/span+AD4- Avoid repeated freeze-thaw cycles. +ADw-/p+AD4- +ADw-p+AD4-Reference: Ohiro Y. et al. FEBS Lett. 2002 Jul 31+ADw-span class+AD0-GramE+AD4AOw-524+ADw-/span+AD4-(1-3):163-71. +ADw-/p+AD4- +ADw-p+AD4-For In Vitro research use only+ADs- not for use in or on humans or animals-not for use in diagnostics +ADw-/p+AD4- +ADw-div class+AD0-MsoNormal align+AD0-center style+AD0-'text-align:center'+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- align+AD0-center+AD4- +ADw-/div+AD4- +ADw-p+AD4-RDI Division of Fitzgerald Industries Intl +ADw-/p+AD4- +ADw-p+AD4APA-st1:Street w:st+AD0AIg-on+ACIAPgA8-st1:address w:st+AD0AIg-on+ACIAPg-34 Junction Square+ADw-/st1:address+AD4APA-/st1:Street+AD4- Drive +ADw-/p+AD4- +ADw-p+AD4APA-st1:place w:st+AD0AIg-on+ACIAPgA8-st1:City w:st+AD0AIg-on+ACIAPg-Concord+ADw-/st1:City+AD4- +ADw-st1:State w:st+AD0AIg-on+ACIAPg-MA+ADw-/st1:State+AD4- +ADw-st1:PostalCode w:st+AD0AIg-on+ACIAPg-01742+ADw-/st1:PostalCode+AD4APA-/st1:place+AD4--3049 +ADw-/p+AD4- +ADw-p+AD4APA-st1:country-region w:st+AD0AIg-on+ACIAPgA8-st1:place w:st+AD0AIg-on+ACIAPg-USA+ADw-/st1:place+AD4APA-/st1:country-region+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-phone+ADw-/span+AD4- (978) 371-6446 or (800) 370-2222 +ADw-/p+AD4- +ADw-p+AD4APA-span class+AD0-GramE+AD4-fax+ADw-/span+AD4- +ACY-nbsp+ADs- +ACY-nbsp+ADs- (978) 371-2266 +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-mailto:antibodies+AEA-fitzgerald-fii.com+ACIAPg-EMAIL:antibodies+AEA-fitzgerald-fii.com+ADw-/a+AD4- +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/absort.htm+ACIAPg-Return +ADw-/a+AD4AJg-nbsp+ADs- (alphabetical antibody page) +ADw-/p+AD4- +ADw-p+AD4APA-a href+AD0AIg-http://www.researchd.com/terms.htm+ACIAPg-Ordering +ADw-/a+AD4-terms +ADw-/p+AD4- +ADw-/div+AD4- +ADw-/body+AD4- +ADw-/html+AD4-